睡眠呼吸暂停器件市场份额，规模，趋势和行业分析报告，通过诊断装置（PSG，呼吸量表，脉搏血管计，Atigraphy设备）;通过治疗装置（PAP，氧气装置，口腔器具）;通过最终用户;按地区：分部预测，2018年 - 2026年

报告摘要

The global sleep apnea devices market was valued at USD 5.14 billion in 2017 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Sleep apnea is a considered as a critical sleeping ailment in which person’s breathing frequently stops and starts. It is observed that if an individual is appeared to be tired and snore louder even after having full night sleep then there are high chances that a person is suffering from sleep apnea.

有三个主要类型的睡眠呼吸暂停,包括de obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Obstructive sleep apnea is the most common form of such ailment that occurs when throat muscles relax. While sleeping, the upper airway becomes blocked repetitively and reduces airflow or stops it completely. Central sleep apnea befalls when muscles that control breathing don’t receive appropriate signals from the brain. Central sleep apnea is comparatively less common disorder than obstructive. On the other hand, complex sleep apnea syndrome, also called as treatment-emergent central sleep apnea, is a disorder when someone a person is suffering from both central sleep apnea as well as obstructive sleep apnea.

了解有关此报告的更多信息：请求样本页面

最常见的症状包括在睡眠期间浇灌空气，早晨头疼，睡觉时停止呼吸的剧集，唤醒口干，令人烦恼。睡眠呼吸暂停的诊断基于症状和标志以及患者历史。在大多数情况下，建议该人访问睡眠障碍中心，专家可以在诊断测试的基础上提供治疗。睡眠呼吸暂停的诊断试验包括家庭睡眠测试和夜间多核心摄影。

任何年龄组都可以受到睡眠呼吸暂停疾病的影响。这种疾病的风险随着年龄的增加而增加。危险因素包括肥胖，过度吸烟，不健康的生活方式习惯和环境，家族史以及遗传学。然而，睡眠呼吸暂停比男性更常见，而且主要是年轻人的女性，然而，差异差异后来。为了治疗睡眠障碍，建议患者健康的生活方式变化，例如戒烟或减肥。此外，对于认真的情况，建议患者对连续正气道压力（CPAP），喉舌，正气道压（PAP）机或植入物等疗法建议。

患有睡眠呼吸暂停的人民不断养成的人是预期推动睡眠呼吸暂停装置需求的主要趋势之一。根据世界卫生组织（世卫组织）报道，睡眠呼吸暂停症的发生量约为1000万全球。在美国，15分中有1人患有严重的OSA（阻塞性睡眠呼吸暂停），而5中的1个患有温和的OSA。此外，大约4200万人患有美国睡眠无序的呼吸（SDB）。即将到来的十年，这些数字可能会增加。预计在即将到期期间，预计又会增加对治疗/诊断设备的需求。

增加技术进步对于有效的诊断和治疗，越来越多的口腔家电睡眠呼吸暂停治疗，以及关于睡眠呼吸暂停的逆转作用的上升意识是其他趋势，估计在预测期内提高行业增长。然而，由于早期结果，替代睡眠呼吸暂停装置的替代治疗方案预计将在未来几年内妨碍市场增长。

Segment Analysis

The global Sleep Apnea Devices market is segmented on the basis of diagnostics devices, therapeutics devices, end-user, and region. On the basis of diagnostics devices, the market is segmented into Polysomnography Devices (PSG), Respiratory polygraphs, Pulse Oximeters and Actigraphy Devices. In 2017, diagnostics devices were estimated to dominate the overall market in terms of revenue. Increasing patient awareness regarding the welfare of early diagnosis were identified as one of the major factors enahcing the usage of diagnostic devices. Due to high patient pool, large number of patient population is estimated to provide significant growth opportunities to the segment further bolstering the market growth. The domestic governments organizations present in different countries present inventiveness that are aimed to limit the high healthcare spending for sleep apnea. Which in turn is anticipated to drive market growth.

基于治疗装置，市场进一步分为气道压力（PAP）器件，氧气装置，口腔器具和自适应伺服通风（ASV）器件。2017年，积极的气道压力（PAP）设备在收入方面占据最大的市场份额。PAP设备被测量为“金标准”以治疗睡眠呼吸暂停。该装置允许加压的气流通过附着在机器上的面罩和确保在睡觉时正常呼吸的管道流过呼吸道气流。根据要求，使用这些设备的使用以及设备定制等附加功能，以进一步估计推动市场增长。

Based on the end users, the market is segmented into hospitals & sleep laboratories and home care settings. The hospitals & sleep laboratories segment was the largest segment during 2017 in terms of revenue. The high market share was attributed to the growing number of patients undertaking sleep testing at majorly at laboratory or a hospital.

睡眠呼吸暂停器件市场范围

通过诊断设备	通过治疗装置	By End User	按地区
多元型摄制装置（PSG） 呼吸量表 Pulse Oximeters Atigrigraphy设备	Positive Airway Pressure (PAP) Devices Oxygen Devices Oral Appliances Adaptive Servo Ventilation (ASV) Devices	医院和睡眠实验室 家庭护理设置	北美（美国，加拿大） 欧洲（德国，英国，法国，意大利，西班牙，比利时，俄罗斯，荷兰，欧洲其他地区） Asia Pacific (China, India, Japan, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of APAC) Latin America (Brazil, Mexico, Argentina, Rest of LATAM) 中东和非洲（阿联酋，沙特阿拉伯，南非，MEA的其他地区）

了解有关此报告的更多信息：请求样本页面

Regional Analysis

该报告包括跨北美，欧洲，亚太地区，拉丁美洲和中东和非洲市场的详细地域分布。北美占2017年最大的区域市场，份额约为40.1％。建立了该地区市场参与者和高患者人口的存在，预计将推动现有的高市场份额。由于保持健康需求很大，美国市场正在大幅增加，因为人们对睡眠呼吸暂停相关的风险很担心。

Moreover, funds and grants provision by government and private organizations, and technologically advanced devices such as Elastic Mandibular Advancements (EMA), for easy and early diagnosis as well as treatment for sleep apnea is another trend estimated boosting the market growth in North America.

Competitive Landscape

The leading players in the report include Fisher & Paykel Healthcare (New Zealand), Koninklijke Philips (Netherlands), ResMed (U.S.), Compumedics (Australia), Whole You (U.S.), BMC Medical (China), Braebon Medical (Canada), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (U.S.), and SomnoMed (Australia). These leading players in the market are introducing innovative products in the market to cater to the consumers. Global players are entering new markets in developing regions to expand their customer base and strengthen presence in the Sleep Apnea Devices market.